TELEFLEX INC

https://www.investing.com/news/pro/teleflex-inc-receives-investment-bank-analyst-rating-update-3093944

https://www.investing.com/news/pro/cl-king-starts-teleflex-at-buy-432SI-3093943

NEWARK, DE / ACCESSWIRE / May 25, 2023 / As per Future Market Insights'' latest industry analysis, the valuation for the USA knotless surgical sutures market was around US$ 175.7 Million in 2022 and is projected to exhibit a CAGR growth of close to 3.6% over the forecast period, with an estimated valuation of US$ 258.7 Million in 2033. Over the years, the USA market for knotless surgical sutures has seen tremendous growth. Key factors driving the market include technological advancements in terms of the usage of synthetic materials in creating surgical sutures, the development of absorbable sutures, increasing export opportunities, and rising disposable income. For insights on global, regional, and country-level parameters with growth opportunities from 2023 to 2033 - Download a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-17299 Leading companies are inclined towards extensive research in order to develop new and improved versions of knotless surgical sutures. These include sutures with synthetic materials to provide exceptional tissue holding properties, sutures with properties like antibacterial or Triclosan-coated polyglactin 910 coated sutures, barbed sutures, sutures with braiding technologies, or absorbable sutures made of fibresthat line animal intestines or artificially created polymers.

Commonwealth Equity Services LLC boosted its position in shares of Teleflex Incorporated (NYSE:TFX – Get Rating) by 1.3% in the fourth quarter, HoldingsChannel reports. The fund owned 4,646 shares of the medical technology company’s stock after purchasing an additional 61 shares during the quarter. Commonwealth Equity Services LLC’s holdings in Teleflex were worth $1,160,000 as […]

Stay up-to-date with Global Lung Cancer Surgery Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth. PUNE, MAHARASHTRA, INDIA, May 11, 2023 /⁨EINPresswire.com⁩/ -- The Latest Released Lung …

Teleflex Incorporated (TFX) fell in the morning hours Wednesday after Wolfe Research downgraded the medical device maker, citing valuation concerns. Read more here.

WAYNE, Pa., April 25, 2023 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Bank of America Securities 2023 Health Care Conference at the Encore Hotel in Las Vegas, Nevada, on Tuesday, May 9, 2023, at 10:00 a.m. (PT).

WAYNE, Pa., April 20, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its first quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, May 4, 2023.

Hartford Investment Management Co. lowered its stake in shares of Teleflex Incorporated (NYSE:TFX – Get Rating) by 24.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,399 shares of the medical technology company’s stock after selling 1,073 shares during the quarter. Hartford Investment […]

Teleflex Incorporated delivered beneficial guidance for the year 2023 and optimistic results in Q4. Click here to see why TFX stock is a Buy.

Teleflex Incorporated found using ticker (TFX) have now 13 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 330 and 215 with the average target price sitting at 250.77. Now with the previous closing price of 225.71 this would imply there is a potential upside of 11.1%. The day 50 moving average is 207.33 and the 200 moving average now moves to 266.01. The market capitalisation for the company is $10,579m. Find out more information at: https://www.teleflex.com [stock_market_widget type="chart" template="basic" color="green" assets="TFX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $11,754m based on the market concensus. Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

ClearBridge Investments, an investment management firm, published its “Mid Cap Growth Strategy” third-quarter 2022 investor letter – a copy of which can be downloaded here. The ClearBridge Mid Cap Growth Strategy underperformed the Russell Midcap Growth Index during the third quarter. On an absolute basis, the Strategy had losses across eight of the 10 sectors […]

WAYNE, Pa., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today has announced it was named a MedReps.com 2023 Best Places to Work, earning the Number 1 spot for large companies and making this the sixth consecutive year the company has been on the list.

According to Market Study Report, Medical Corrugated Tubing Market provides a comprehensive analysis of the Medical Corrugated Tubing Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in

WAYNE, Pa., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 34 th Annual Piper Sandler Healthcare Conference at The Lotte New York Palace, New York, NY, on Wednesday, November 30, 2022 at 1:30 p.m. (ET).